What low-tech tools or methods do you use in your urology practice?

In total, 28% of patients with luminal tumors and 41% of patients with non-luminal tumors experienced upstaging to non-organ confined disease.

Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.

The primary end point is 12-month radiographic progression-free survival.

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.

The data also showed that mortality plateaued in recent years despite declining in years prior.

"Wearable devices are increasingly being used to understand and improve male sexual dysfunctions," write the authors.